Biohaven (BHVN) Cash from Financing Activities (2021 - 2026)
Biohaven has reported Cash from Financing Activities over the past 6 years, most recently at $179.0 million for Q1 2026.
- Quarterly results put Cash from Financing Activities at $179.0 million for Q1 2026, up 48413.82% from a year ago — trailing twelve months through Mar 2026 was $617.8 million (down 8.44% YoY), and the annual figure for FY2025 was $439.1 million, down 35.21%.
- Cash from Financing Activities reached $179.0 million in Q1 2026 per BHVN's latest filing, down from $188.8 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $530.2 million in Q4 2022 and bottomed at -$39.7 million in Q3 2023.
- Median Cash from Financing Activities over the past 5 years was $86.8 million (2022), compared with a mean of $133.8 million.
- The largest annual shift saw Cash from Financing Activities tumbled 131.09% in 2023 before it skyrocketed 48413.82% in 2026.
- Over 5 years, Cash from Financing Activities stood at $530.2 million in 2022, then tumbled by 53.74% to $245.2 million in 2023, then rose by 11.26% to $272.9 million in 2024, then plummeted by 30.81% to $188.8 million in 2025, then dropped by 5.18% to $179.0 million in 2026.
- Business Quant data shows Cash from Financing Activities for BHVN at $179.0 million in Q1 2026, $188.8 million in Q4 2025, and $122000.0 in Q3 2025.